Skip to content

PrEP failures in African programmes are rare, but some are happening in people with good adherence

Slide from Dr Urvi Parikh's presentation to IAS 2021.

PrEP for women in Europe webinar: Part 2

PrEP for women in Europe webinar: Part 2

PrEP for women in Europe webinar: Part 1

PrEP for women in Europe webinar: Part 1

Users of event-driven PrEP take it when needed, Dutch study finds

Graphic showing correlation between intracellular tenofovir levels, reported PrEP use, and occasions of risky uses

Top 5 stories on injectable HIV treatment and prevention from CROI 2021

Professor Raphael Landovitz presenting findings on injectable PrEP to CROI 2021.

PrEP does not lower hormone levels in young transgender people, but lower PrEP levels seen in some transgender women

A young transgender woman looking in the bathroom mirror. The Gender Spectrum Collection. Image is for illustrative purposes only.

HPTN 083: Injectable PrEP can make breakthrough infections hard to detect

Professor Raphael Landovitz presenting to CROI 2021.

Antibiotics to prevent STIs – for or against?

Professor Jean-Michel Molina presenting to HIVR4P 2021.

Once-a-month PrEP pill easily passes its first big test

Professor Sharon Hillier at HIVR4P